It’s a New Day – A Breakthrough in Renal and Cardiac Benefits


Click here to view in chapters format

Learning Objectives

    At the conclusion of this activity, participants will be able:
  • To summarize the renal and cardiovascular complications of diabetes
  • To describe the results from SGLT2 inhibitor trials in type 2 diabetes populations
  • To interpret how the management of type 2 diabetes will evolve with the newer antihyperglycemic agents

Agenda

00:00:00 Welcome and Opening Remarks
Dr. Bernard Zinman
00.09:23 The burden of renal disease in diabetes and our current gold standard treatments
Dr. David Cherney
00.29:05 The cardiovascular burden in people with type 2 diabetes and chronic kidney disease
Dr. Subodh Verma
00.50:32 What we have learned about SGLT2 inhibitors prior to CREDENCE
Dr. Lawrence Leiter
01:16:28 Keynote Lecture: The CREDENCE Trial – A New Day in Diabetes
Dr. Vlado Perkovic
0
1:54:56 Clinical implications and knowledge translation of the data from CREDENCE (Interactive panel discussion)
NEPHROLOGY perspective: Dr. Christopher Chan, CARDIOVASCULAR perspective: Dr. Subodh Verma, ENDOCRINE perspective: Dr. Irene Hramiak, PRIMARY CARE perspective: Dr. Alan Bell
02:23:42 Presenter Q+A

Faculty


Bernard Zinman
CM, MD, FRCPC, FACP
CHAIR
Stephen and Suzie Pustil Diabetes
Research Scientist; Lunenfeld-Tanenbaum
Research Institute, Mount Sinai Hospital;
Professor of Medicine,
University of Toronto
Toronto, ON

Christopher T. M. Chan
MD, FRCPC
Nephrologist and Division Head,
University Health Network;
Professor of Medicine,
University of Toronto,
Toronto, ON

David Z.I. Cherney
MD, CM, PhD, FRCPC
Nephrologist, University Health Network
and Mount Sinai Hospital
Associate Professor of Medicine,
University of Toronto
Toronto, ON

Vlado Perkovic
MBBS, PhD, FASN, FRACP
Nephrologist, Royal North Shore Hospital;
Executive Director, The George Institute;
Professor of Medicine,
University of New South Wales,
Sydney, NSW, Australia

Lawrence A. Leiter
MD, FRCPC, FACP, FACE, FAHA, FACC
Endocrinologist,
St. Michael’s Hospital;
Professor of Medicine and Nutritional
Sciences, University of Toronto,
Toronto, ON

Irene M. Hramiak
MD, FRCP(C), FACP
Chief, Centre for Diabetes,
Endocrinology and Metabolism,
St. Joseph’s Health Care;
Professor of Medicine, Western University,
London, ON

Video Information
  • Credit:No Credit Available
  • Post Date:April 27, 2019
  • Expiry Date:N/A

Related Videos